Stemcell Holdings Inc (STMM)
0.06
0.00 (0.00%)
USD |
OTCM |
Apr 23, 16:00
Stemcell Holdings Cash from Operations (TTM): 2.544M for Sept. 30, 2018
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| September 30, 2018 | 2.544M |
| June 30, 2018 | 1.338M |
| March 31, 2018 | 3.675M |
| December 31, 2017 | 2.523M |
| Date | Value |
|---|---|
| September 30, 2017 | 3.485M |
| June 30, 2017 | 5.296M |
| March 31, 2017 | 3.272M |
| December 31, 2016 | 3.366M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| AIM ImmunoTech Inc | -21.27M |
| Perspective Therapeutics Inc | -36.91M |
| Protalix BioTherapeutics Inc | -1.318M |
| Electromed Inc | 4.872M |
| Armata Pharmaceuticals Inc | -47.42M |